Journal List > Korean J Nutr > v.43(1) > 1043806

Han, Kim, Cheong, Chee, and Chee: Bioavailability and Digestibility of Organic Calcium Sources by Bone Health Index

Abstract

This study was carried out to evaluate the bioavailabilities and the digestibilities of oligopeptide chelated (peptide-Ca), anchovy bone (anchovy-Ca) and methionine hydroxyl analogue (MHA-Ca) calcium compared to those of calcium carbonate in rats. In exp1, CaCO3, were added to the basal diet at level of 0, 30 and 60% calcium of the AIN-93G diet. In test groups, peptide-Ca, anchovy-Ca and MHA-Ca, were added to the basal diet to provide calcium at the level of 40% of AIN-93G. In exp1, the bioavailabilities were evaluated from the regression equation of the ratios of theological/actual calcium intakes of each dietary treatment. In exp2, urine and feces was to evaluate the true- and apparent digestibility and apparent retention. In exp1, Ca-60% group had higher bone mineral density (BMD), bone mineral content (BMC) and bone breaking strength (BBS) than those of the other standard groups. The bone weight and ash content of the peptide-Ca and anchovy-Ca groups were significantly higher than those of the MHA-Ca. Bone calcium content were not significantly different from the test group. The bioavailability of the MHA-Ca group was shown higher BMD (71%), BS (38%) and BBS (27%) compared to another control group. But the regression coefficient for BMD, BS and BBS were lower compare with that of bone ash and BMC. In exp2, the true- and apparent digestibility of test groups were shown to over 90%. Peptide-Ca was not significantly different from other test group, but digestibility and retention were higher compare to other test groups. In conclusion, peptide-Ca, anchovy-Ca and MHA-Ca improved Ca bioavailability in the rats. The compounds were higher Ca digestibility compared with those of CaCO3. It is assumed that difference of digestibility for test groups may be correlated to the bioavailability of test groups in BMD, BMC, BS, BBS and bone ash respectively.

Figures and Tables

Fig. 1
Relationship between BMD and Ca intake from calcium standard diets groups.
kjn-43-12-g001
Fig. 2
Relationship between BMC and Ca intake from calcium standard diets groups.
kjn-43-12-g002
Fig. 3
Relationship between BS and Ca intake from calcium standard diets groups.
kjn-43-12-g003
Fig. 4
Relationship between BBS and Ca intake from calcium standard diets groups.
kjn-43-12-g004
Fig. 5
Relationship between bone ash (%) and Ca intake (mg/rat/day) from calcium standard diets groups.
kjn-43-12-g005
Table 1
Composition of diets (%) for calcium bioavailability test (Experiments 1, 2)
kjn-43-12-i001

1) Calcium carbonate, reagent grade, was added to the basal diet to provide 0% (Ca 0%), 30% (Ca 0.15%), and 60% (Ca 0.30%) of calcium requirement in AIN-93G diet for young rats.

2) Each calcium source was added to the basal diet to provide 40% of calcium requirement in AIN-93G diet for young rats

3) Reagent grade chemical (Yakuri, Japan)

4) Sampung BnF (oligo-peptide chelated Ca)

5) Commercial dry-anchovy (only bone)

6) Methionine hydroxy analogue Ca (Novos International, Inc., U.S.A)

7) Acid casein (NZMP Ltd., Wellington, New Zealand) contains 92% crude protein. The casein's calcium level is 19 mg/100 g casein.

8) Others include corn starch, 35%; Soybean oil, 7%; cellulose, 5%; sodium chloride, 0.26; AIN-VX Vitamin Mix, Dyets 310025 (Behtlehem, PA), 1%; mineral mix (Ca free), 3.5%; KH2PO4, 0.55%; choline bitarate, 0.2%; DL-Methionine, 0.2%

Table 2
Analyzed and calculated calcium contents of the calcium sources, and experimental diets
kjn-43-12-i002

1) Theoretical calcium content (%). Reagent grade CaCO3 (Ca 40.1%)

Table 3
Instron conditions for bone breaking strength and bone stiffness
kjn-43-12-i003
Table 4
AAS conditions for calcium analysis
kjn-43-12-i004
Table 5
Body weight gain, feed intake, calcium intake and FER in rats fed the experimental diets for 3 weeks1)
kjn-43-12-i005

1) Data are means ± SEM. Means with different superscript letters are significantly different (p < 0.05)

2) FER (Food efficiency ratio): Body weight gains (g)/Feed intake (g) for 3 weeks

Table 6
Ca bioavailability based on body weight gain in rats fed the diets containing various Ca sources
kjn-43-12-i006

1) Added at 40% of NRC

2) Calculated by feed intake (mg/rat/day) × ratio of calcium content in experimental diet

3) Calculated by equation (y = 0.064x + 3.974, R2 = 0.774)

Theoretical Ca intake (mg/rat/day) = {Body weight gain (g/rat/day) - 3.974}/ 0.064

4) Calculated as bioavailability (%) = Theoretical Ca intake/Actual Ca intake × 100

Table 7
Total bone mineral density (TBMD), total bone mineral content (TBMC), total bone area, bone mineral density (BMD), bone mineral content (BMC), bone area in rats fed the experimental diets for 3 weeks
kjn-43-12-i007

1) Sum of group's total data

2) Data are means ± SEM. Means with different superscript letters are significantly different (p < 0.05)

ROI: region of interest

Table 8
Ca bioavailability based on bone mineral density (BMD) in rats fed the diets containing various Ca sources
kjn-43-12-i008

1) Added at 40% of NRC

2) Calculated by feed intake (mg/rat/day) × ratio of calcium content in Actual diet

3) Calculated by equation (y = 0.001x + 0.045, R2 = 0.916). Theoretical Ca intake (mg/rat/day) = {BMD (g/cm2) - 0.045}/ 0.001

4) Calculated as bioavailability (%) = Theoretical Ca intake/Actual Ca intake × 100

Table 9
Ca bioavailability based on bone mineral content (BMC) in rats fed the diets containing various Ca sources
kjn-43-12-i009

1) Added at 40% of NRC

2) Calculated by feed intake (mg/rat/day) × ratio of calcium content in experimental diet

3) Calculated by equation (y = 0.221x + 5.133, R2 = 0.935). Theoretical Ca intake (mg/rat/day) = {BMC (g) - 5.133}/ 0.221

4) Calculated as bioavailability (%) = Theoretical Ca intake/Actual Ca intake × 100

Table 10
Bone length, bone stiffness (BS) and bone breaking strength (BBS) in rats fed the experimental diets for 3 weeks1)
kjn-43-12-i010

1) Data are means ± SEM. Means with different superscript letters are significantly different (p < 0.05)

Table 11
Ca bioavailability based on bone stiffness (BS) in rats fed the diets containing various Ca sources
kjn-43-12-i011

1) Added at 40% of NRC

2) Calculated by feed intake (mg/rat/day) × ratio of calcium content in experimental diet

3) Calculated by equation (y = 2.295x + 24.16, R2 = 0.805). Theoretical Ca intake (mg/rat/day) = {BS (N/mm) - 24.16}/ 2.295

4) Calculated as bioavailability (%)= Theoretical Ca intake/Actual Ca intake × 100

Table 12
Ca bioavailability based on bone bone breaking strength (BBS) in rats fed the diets containing various Ca sources
kjn-43-12-i012

1) Added at 40% of NRC

2) Calculated by feed intake (mg/rat/day) × ratio of calcium content in experimental diet

3) Calculated by equation (y = 0.997x + 14.75, R2 = 0.817). Theoretical Ca intake (mg/rat/day) = {BBS (N) - 14.75}/ 0.997

4) Calculated as bioavailability (%) = Theoretical Ca intake/Actual Ca intake × 100

Table 13
Bone weight, ash, calcium and serum calcium in rats fed the experimental diets for 3 weeks1)
kjn-43-12-i013

1) Data are means ± SEM. Means with different superscript letters are significantly different (p < 0.05)

2) Fat free dry weight

Table 14
Ca bioavailability based on bone ash in rats fed the diets containing various Ca sources1)
kjn-43-12-i014

1) Added at 40% of NRC

2) Calculated by feed intake (mg/rat/day) × ratio of calcium content in experimental diet

3) Calculated by equation (y = 0.427x + 31.21, R2 = 0.980). Theoretical Ca intake (mg/rat/day) = {Bone ash (%) - 31.21}/ 0.427

4) Calculated as bioavailability (%) = Theoretical Ca intake/Actual Ca intake × 100

Table 15
Body weight gain, feed intake, calcium intake and FER in rats fed the experimental diets for 6days1)
kjn-43-12-i015

1) Data are means ± SEM. Means with different superscript letters are significantly different (p < 0.05)

2) FER (Food efficiency ratio): Body weight gains (g) / Feed intake (g) for 6 days

Table 16
True - and apparent digestibility, and apparent retention in rats fed the experimental diets for 6 days1)
kjn-43-12-i016

1) Data are means ± SEM. Means with different superscript letters are significantly different (p < 0.05)

2) True digestibility (%) = (Ca intake - Ca in feces - Ca in feces of Ca 0%)/Ca intake × 100. Apparent digestibility (%)= (Ca intake - Ca in feces)/Ca intake × 100. Apparent retention (%)= (Ca intake - Ca in feces - Ca in urine)/Ca intake × 100

References

1. The Korean Nutrition Society. Dietary Reference Intakes for Koreans. 2005. Seoul:
2. Korea Centers for Disease Control and Prevention. The third Korea National Health and Nutrition Examination Survey (KNHANES III). 2005.
3. Allen LH, Wood RJ. Shils ME, Olson JA M, editors. Calcium and phosphorus. Modern Nutrition in Health and Disease. 1994. 8th Ed. 144–163.
4. Allen LH. Calcium bioavailability and absorption: a review. Am J Clin Nutr. 1982. 35:783–808.
crossref
5. Linder MC. Linder MC, editor. Nutrition and metabolism of major minerals. Nutritional biochemistry and metabolism with clinical application. 1991. New York: Elsevier;191–214.
6. Levenson DI, Bockman RS. A review of calcium preparations. Nutr Rev. 1994. 52:221–232.
crossref
7. Smith EL, Gilligan C, Smith PE, Sempos CT. Calcium supplementation and bone loss in middle-aged woman. Am J Clin Nutr. 1989. 50:833–842.
8. Coe FL, Parks JH. Recurrent renal calcium. Cause and Prevention. Hosp Prac. 1986. 30:49–45.
9. Yendt ER, Cohanim M, Jarzylo S. Reduced glomerular filtration and a renal tubular Ca leak in womae with primary osteoporosis. J Bone Min Res. 1989. 4(s):253–256.
10. Sobal J, Muncie HL. Vitamin/mineral supplements use among adolescent. J Nutr Edu. 1988. 20(6):314–318.
11. Korean Pharmaceutical Association. Production sheet of medicines pharmaceutics in Korea. 1995. Seoul:
12. Heribert J, Watzke A. Impact of processing on bioavailability examples of minerals in foods. Trends in Food Sci & Technol. 1998. 9:320–332.
crossref
13. Susan J, Fairweather-Tait SJ. Forti , editor. Iron and Calcium Bioavaila-bility. Foods and Dietary Supplements. 2002. New York: International Life Sciences Institute;360–367.
14. Fairweather-Tait SJ, Teucher B. Calcium bioavailability in relation to bone health. Int J Vitam Nutr Res. 2001. 72:13–18.
crossref
15. Gueguen L, Pointillart A. The bioavailability of dietary calcium. J Am Coll Nutr. 2000. 19:2 Suppl. 119S–136S.
16. Robert PH. Factors Influencing the Measurement of Bioavailability, Taking Calcium as a Model1. 2001. Am Society for Nutritional Sciences.
17. Sakhaee K, Bhuket T, Adams-Huet B, Rao DS. A meta-analysis of calcium bioavailability: a comparison of calcium citrate with calcium carbonate. Am J Ther. 1999. 6:313–321.
18. Sheikh MS, Anta ACA, Nicar MJ. Gastrointestinal absorptions of calcium from milk and calcium salt. N Engl J med. 1987. 317:532–536.
crossref
19. Chung HK, Chang N, Lee HS, Chang YE. The effect of various types of calcium sources on calcium and bone metabolism in rats. Korean J Nutr. 1996. 29(5):480–488.
20. Morohashi T, Sano T, Ohta A, Yamada S. True calcium absorption in intestine is enhanced by fructooligosaccharide feeding in rats. J Nutr. 1998. 128:1815–1818.
crossref
21. Harms RH, Russell GB. Adding methionine and lysine to broiler breeder diets to lower feed costs. J Appl Poult Res. 1998. 7(2):202–218.
crossref
22. Lewis AJ. Ammerman CB, Baker DH, Lewis AJ, editors. Bioavailability of D-amino acids and DL-Hydroxymethionine. Bioavailability of Nutrients for Animals. 1995. San Diego: Academic Press;67–81.
crossref
23. Turner RT. Basic Biomechanical Measurements of Bone. A Tutorial Bone. 1993. 14:595–608.
24. Rath NC, Huff WE, Balog JM, Bayyari GR. Effect of gonadal steroids on bone and other physiological parameters of male broiler chickens. Poul Sci. 1996. 75:556–562.
crossref
25. Guéguen L, Pointillart A. The Bioavailability of Dietary Calcium. J Am Coll Nutr. 2000. 19:2 Suppl. 119S–136S.
crossref
26. Kwon OR, Kim MK. Effects of dietary Ca levels and kinds of lipid on the lipid metabolism in the rats. Korean J Nutr. 1988. 21(5):324–332.
27. Lee JH, Moon SJ, Huh KB. Influence of phytate and low dietary calcium on calcium, phosphate and zinc metabolism by growing rats. Korean J Nutr. 1993. 26(2):145–155.
28. Yacowitz H. Effects of dietary calcium upon lipid metabolism in rats fed saturated or unsaturated fat. J Nutr. 1967. 92:389–392.
crossref
29. Iacono JM. Effect of varying dietary level of calcium on plasma and tissue lipids of rabbits. J Nutr. 1974. 104:1165–1171.
crossref
30. Foley MK. Influence of dietary calcium and cholecalciferol on composition of plasma lipids in young pigs. J Nutr. 1990. 120:45–51.
crossref
31. Duan Y, Parfitt AM, Seeman E. Vertebral bone mass, size, and volumetric density in women with spinal fractures. J Bone Miner Res. 1999. 14:1796–1802.
crossref
32. Cordey J, Schneider M, Belendez C, Ziegler WJ, Rahn BA, Perren SM. Effect of bone size, not density, on the stiffness of the proximal part of normal and osteoporotic human femora. J Bone Miner Res. 1992. 7:Suppl2. S437–S444.
crossref
33. Vega E, Ghiringhelli G, Mautalen C, Rey VG, Scaglia H, Zylberstein C. Bone mineral density and bone size in men with primary osteoporosis and vertebral fractures. Calcif Tissue Int. 1998. 62:465–469.
crossref
34. Roberfroid MB, Cumps J, Devogelaer JP. Dietary chicory inulin increases whole body bone mineral density in growing male rats. J Nutr. 2002. 132:3599–3602.
crossref
35. Mehta S. Bone elasticity and ultrasound velocity are affected by subtle change in organic matrix. J Bone Miner Res. 1998. 13:114–119.
crossref
36. Rath NC. Factors regulating bone maturity and strength in poultry. Poult Sci. 2000. 79:1024–1032.
crossref
37. Meulen MCH. Understanding bone strength: size isn't everything. Bone. 2001. 29:101–104.
crossref
38. Lee SH, Hwangbo YS, Kim JY, Lee YS. A study on the bioavailability of dietary calcium sources. Korean J Nutr. 1997. 30(5):499–505.
39. Ezawa I. Studies on calcium metabolism. Jap J Home Econo. 1987. 38:695–703.
40. Benson JD. Effect of previous calcium intake on adaptation to low and high calcium diets in rats. J Nutr. 1969. 97:53–60.
crossref
41. Sammom PE. Role of parathyroid hormone in calcium homeostasis and metabolism. Am J Physiol. 1970. 218:479–485.
crossref
42. Roland DA. Calcium metabolism in the laying hen: The calcium status of the hen at night. Poult Sci. 1973. 52:351–354.
43. Matkovic V. Factors that influence peak bone mass formation: A study of calcium balance and the inheritance of bone mass in adolescent females. Am J Clin Nutr. 1990. 52:878–888.
crossref
TOOLS
Similar articles